Arthritis may raise dangerous leg and lung blood clots risk

Image
ANI Washington
Last Updated : Aug 08 2013 | 9:55 AM IST

Risk of potentially fatal blood clots in the legs and lungs are increased by rheumatoid arthritis, a nationwide study has claimed.

According to the evidence, between 11 percent and 30 percent of people who develop a blood clot in the legs, known as a deep vein thrombosis or DVT, or a blood clot in the lungs, known as a pulmonary embolism, or PE, die within 30 days of their diagnosis.

Researchers tracked the health of most of the population of Taiwan (23.74 million people) through the country's compulsory national insurance scheme between 1998 to 2008, and included a further monitoring period up to the end of 2010, to find out if rheumatoid arthritis raised the risk of potentially fatal blood clots.

Just less than 30,000 people developed rheumatoid arthritis during this period, and their details were entered into a national (catastrophic illness) registry of the National Health Insurance Database (NHIRD). By way of comparison, they were matched with almost 117,000 healthy people of the same age and sex.

Patients with rheumatoid arthritis were more likely to have other underlying conditions, like high blood pressure, diabetes, high cholesterol, heart failure and fractures, than were those in the comparison group.

But even after taking account of these influential factors, and allowing for age, patients with rheumatoid arthritis were still significantly more likely to develop potentially fatal blood clots, the analysis revealed.

They were more than three times as likely to develop a DVT, and twice as likely to develop a PE as those without the condition, the figures showed.

Furthermore, rheumatoid arthritis packed the greatest punch in the under 50s, who were almost six times as likely to develop a DVT and more than three times as likely to develop PE than were either middle aged (50 to 65) or older adults.

The findings of the study have been published online in the Annals of the Rheumatic Diseases.

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Aug 08 2013 | 9:54 AM IST

Next Story